eslicarbazepine acetate has been researched along with Aura in 51 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (9.80) | 29.6817 |
| 2010's | 37 (72.55) | 24.3611 |
| 2020's | 9 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| Dipper-Wawra, M; Fidzinski, P; Holtkamp, M; Kraus, L; Maier, N; Monni, L; Schmitz, D; Soares-da-Silva, P | 1 |
| Groppa, S; Sandner, K; Vieth, T; Winter, Y | 1 |
| Kim, DW; Kwack, DW | 1 |
| Hirsch, M; Immisch, I; Knake, S; Schulze-Bonhage, A | 1 |
| Lawthom, C; Maguire, M; O'Dwyer, M; Oak, K; Shankar, R; Thomas, R; Watkins, L | 1 |
| Chaves, J; Fernandes, H; Loureiro, R; McMurray, R; Sales, F; Villanueva, V | 1 |
| Bak, LK; Jakobsen, E; Krarup, S; Lindholm, SEH; Mertz, C; Pinborg, LH | 1 |
| Allard, J; Ellawela, S; Henley, W; Hudson, S; Lawthom, C; Mclean, B; Pace, A; Rajakulendran, S; Shankar, R; Tittensor, P | 1 |
| Alfaro-Sáez, A; Asensio-Asensio, M; Bertol-Alegre, V; Blanco-Cantó, ME; Castro-Vilanova, MD; Díaz-Román, M; Galiano, ML; García-Escrivá, A; Hernández-Rubio, L; López-González, F; Méndez-Miralles, MA; Montoya, J; Tortosa-Conesa, D | 1 |
| Brodie, MJ; Stephen, LJ; Wishart, A | 1 |
| Brienza, M; Davassi, C; Franco, V; Mecarelli, O; Pulitano, P; Russo, E | 1 |
| Ahmed, A; Henley, W; Jalihal, V; McLean, BN; Parrett, M; Sander, JW; Shankar, R; Tittensor, P | 1 |
| Gama, H; Jóźwiak, S; Moreira, J; Rocha, F; Soares-da-Silva, P; Veggiotti, P | 1 |
| Rocha, JF; Soares-da-Silva, P; Trinka, E | 1 |
| Brigo, F; Lattanzi, S | 1 |
| Intravooth, T; Juerges, K; Staack, AM; Steinhoff, BJ; Stockinger, J | 1 |
| Costa, R; Gama, H; Graça, J; Magalhães, LM; Moreira, J; Rocha, JF; Soares-da-Silva, P; Vieira, M | 1 |
| Andersen, NB; Diemar, SS; Jørgensen, NR; Sejling, AS | 1 |
| Herranz, JL | 1 |
| Anastassopoulos, KP; Blum, D; Cramer, JA; Rajagopalan, K | 1 |
| Boyd, A; Falco-Walter, J; Le, S; Loring, DW; Meador, KJ; Razavi, B; Seliger, J | 1 |
| Castro-Vilanova, D; Gómez-Eguilaz, M; Mauri, JA; Mazuela, G; Rodriguez-Osorio, X; Rodriguez-Uranga, J; Santamarina, E; Toledo, M | 1 |
| Assenza, G; Boero, G; Chaves, J; Doherty, CP; McMurray, R; Rheims, S; Villanueva, V | 1 |
| Alvarez, BM; Baiges, JJ; Bermejo, P; Bertol, V; Bonet, M; Castro-Vilanova, MD; Esteve, P; Galiano, ML; Garcés, M; Giner, P; Hampel, K; López-González, FJ; Massot-Tarrús, A; Mauri, JÁ; Montoya, J; Ojeda, J; Poza, JJ; Quiroga-Subirana, P; Rodríguez-Osorio, X; Rodriguez-Uranga, JJ; Ruiz-Giménez, J; Toledo, M; Tortosa-Conesa, D; Villanueva, V | 1 |
| Cimadevilla, JM; Fernández-Pérez, J; Payán-Ortiz, M; Quiroga-Subirana, P; Serrano-Castro, PJ | 1 |
| Loiacono, G; Rossi, A; Verrotti, A; Zaccara, G | 1 |
| Biswas, D; Hameed, N; Kamal, MA; Khan, M; Rizvi, SM; Shaikh, S; Shakil, S | 1 |
| Beck, H; Bonifácio, MJ; Dickhof, G; Doeser, A; Pires, NM; Reitze, M; Schaub, C; Soares-da-Silva, P; Uebachs, M | 1 |
| Lerche, H | 1 |
| Holtkamp, M; Peltola, J; Rocamora, R; Ryvlin, P; Sieradzan, K; Villanueva, V | 1 |
| Jiménez-Conde, J; Ley, M; Principe, A; Rocamora, R | 1 |
| Blum, D; Cheng, H; French, J; Gough, M; Grinnell, T; Jacobson, MP; Pazdera, L; Sperling, MR | 1 |
| Benbadis, SR; Giarratano, M; Gierbolini, J | 1 |
| Mula, M | 1 |
| Bathal, H; Ojeda, J; Parra, J; Rocamora, RA; Rodríguez-Uranga, JJ; Serrano-Castro, PJ; Villanueva, V; Viteri, C | 1 |
| Holtkamp, M; Kockelmann, E; Lendemans, D; Losch, FP; McMurray, R | 1 |
| Mäkinen, J; Peltola, J; Rainesalo, S | 1 |
| Almeida, L; Butoianu, N; Falcão, A; Magureanu, SA; Minciu, I; Nunes, T; Soares-da-Silva, P | 1 |
| Almeida, L; Brunet, JS; Falcão, A; Lefebvre, M; Nunes, T; Rocha, JF; Sicard, E; Soares-da-Silva, P | 1 |
| Almeida, L; Cramer, JA; Członkowska, A; Elger, C; Guekht, A; Halász, P; Hodoba, D; Maia, J; Soares-da-Silva, P | 1 |
| Steinhoff, BJ; Trinka, E; Wendling, AS | 1 |
| Alves, G; Bicker, J; Falcão, A; Fortuna, A; Soares-da-Silva, P | 1 |
| Szupera, Z | 1 |
| Berry, DJ; Patsalos, PN | 1 |
| Bialer, M; Soares-da-Silva, P | 1 |
| Almeida, L; Ben-Menachem, E; Falcão, A; Gabbai, AA; Hufnagel, A; Soares-da-Silva, P | 1 |
| Almeida, L; Soares-da-Silva, P | 2 |
| Ambrósio, AF; Araújo, IM; Carvalho, AP; Carvalho, CM; Leal, EC; Malva, JO; Soares-da-Silva, P; Verdasca, MJ | 1 |
| Ambrósio, AF; Carvalho, AP; Carvalho, CM; Soares-Da-Silva, P | 1 |
12 review(s) available for eslicarbazepine acetate and Aura
| Article | Year |
|---|---|
The evidence for switching dibenzazepines in people with epilepsy.
Topics: Anticonvulsants; Carbamazepine; Dibenzazepines; Drug Substitution; Epilepsy; Evidence-Based Medicine; Humans | 2020 |
Eslicarbazepine acetate exposure in pregnant women with epilepsy.
Topics: Anticonvulsants; Dibenzazepines; Epilepsy; Female; Humans; Pregnancy; Pregnancy Complications; Pregnancy Outcome | 2018 |
Health-related quality of life in patients treated with eslicarbazepine acetate monotherapy: Pooled analysis from two registered clinical trials.
Topics: Adult; Anticonvulsants; Clinical Trials, Phase III as Topic; Dibenzazepines; Double-Blind Method; Epilepsy; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome | 2019 |
Eslicarbazepine acetate: an update on efficacy and safety in epilepsy.
Topics: Animals; Anticonvulsants; Clinical Trials as Topic; Dibenzazepines; Epilepsy; Humans; Treatment Outcome | 2014 |
Eslicarbazepine acetate (aptiom) for epilepsy.
Topics: Animals; Dibenzazepines; Dizziness; Epilepsy; Fatigue; Humans; Prodrugs; Randomized Controlled Trials as Topic | 2014 |
Carbamazepine-related antiepileptic drugs for the treatment of epilepsy - a comparative review.
Topics: Anticonvulsants; Carbamazepine; Dibenzazepines; Drugs, Generic; Epilepsy; Humans; Oxcarbazepine | 2016 |
Third generation antiepileptic drug monotherapies in adults with epilepsy.
Topics: Acetamides; Adult; Anticonvulsants; Dibenzazepines; Epilepsy; Humans; Lacosamide; Time Factors | 2016 |
[New antiepileptic drugs, and therapeutic considerations].
Topics: Acetamides; Anticonvulsants; Carbamates; Dibenzazepines; Epilepsy; Humans; Lacosamide; Phenylenediamines | 2011 |
Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate.
Topics: Acetamides; Anticonvulsants; Carbamates; Dibenzazepines; Drug Interactions; Epilepsy; Humans; Lacosamide; Phenylenediamines | 2012 |
Pharmacokinetics and drug interactions of eslicarbazepine acetate.
Topics: Animals; Anticonvulsants; Dibenzazepines; Dose-Response Relationship, Drug; Drug Interactions; Epilepsy; Humans; Metabolic Networks and Pathways; Microsomes, Liver | 2012 |
Eslicarbazepine acetate (BIA 2-093).
Topics: Animals; Anticonvulsants; Brain; Clinical Trials as Topic; Dibenzazepines; Epilepsy; Humans | 2007 |
Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024.
Topics: Animals; Anticonvulsants; Carbamazepine; Dibenzazepines; Epilepsy; Humans; Oxcarbazepine; Sodium Channel Blockers | 2002 |
9 trial(s) available for eslicarbazepine acetate and Aura
| Article | Year |
|---|---|
Effects of adjunctive eslicarbazepine acetate on neurocognitive functioning in children with refractory focal-onset seizures.
Topics: Adolescent; Anticonvulsants; Attention; Child; Cognition; Combined Modality Therapy; Dibenzazepines; Double-Blind Method; Epilepsy; Female; Humans; Male; Memory; Quality of Life; Seizures; Treatment Outcome | 2018 |
Comparative neuropsychological effects of carbamazepine and eslicarbazepine acetate.
Topics: Adolescent; Adult; Affect; Anticonvulsants; Attention; Carbamazepine; Cross-Over Studies; Dibenzazepines; Double-Blind Method; Epilepsy; Female; Healthy Volunteers; Humans; Male; Memory; Middle Aged; Neuropsychological Tests; Psychomotor Performance; Spatial Memory; Stroop Test; Treatment Outcome; Young Adult | 2019 |
[Eslicarbazepine acetate in clinical practice. Efficacy and safety results].
Topics: Acetamides; Adolescent; Adult; Aged; Anticonvulsants; Cognition Disorders; Depression; Dibenzazepines; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; Female; Follow-Up Studies; Humans; Lacosamide; Male; Middle Aged; Sodium Channel Blockers; Weight Gain; Young Adult | 2013 |
Conversion to eslicarbazepine acetate monotherapy: A pooled analysis of 2 phase III studies.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Dibenzazepines; Epilepsy; Female; Humans; Male; Middle Aged; Young Adult | 2016 |
[Anticonvulsant add-on therapy with Eslicarbazepine acetate : Results of the EPOS-study in adults in Germany].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Causality; Chemotherapy, Adjuvant; Comorbidity; Dibenzazepines; Dizziness; Dose-Response Relationship, Drug; Epilepsy; Fatigue; Female; Germany; Headache; Humans; Male; Middle Aged; Prevalence; Quality of Life; Risk Factors; Treatment Outcome; Voltage-Gated Sodium Channel Blockers; Young Adult | 2016 |
Pharmacokinetic interaction study between eslicarbazepine acetate and lamotrigine in healthy subjects.
Topics: Administration, Oral; Adolescent; Adult; Anticonvulsants; Area Under Curve; Dibenzazepines; Drug Interactions; Drug Therapy, Combination; Epilepsy; Humans; Lamotrigine; Male; Middle Aged; Triazines; Young Adult | 2010 |
Long-term efficacy and safety of eslicarbazepine acetate: results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Dibenzazepines; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Epilepsies, Partial; Epilepsy; Female; Health Status; Humans; Intention to Treat Analysis; Longitudinal Studies; Male; Middle Aged; Quality of Life; Surveys and Questionnaires; Treatment Outcome | 2010 |
Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: results of a 1-year open-label extension study.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Dibenzazepines; Double-Blind Method; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy; Female; Humans; Male; Middle Aged; Time Factors; Treatment Outcome; Young Adult | 2013 |
Safety, tolerability and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic agent, during first administration to humans.
Topics: Administration, Oral; Adolescent; Adult; Anticonvulsants; Carbamazepine; Dibenzazepines; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy; Humans; Male; Metabolic Clearance Rate; Middle Aged; Oxcarbazepine; Time Factors | 2003 |
30 other study(ies) available for eslicarbazepine acetate and Aura
| Article | Year |
|---|---|
In vitro and in vivo anti-epileptic efficacy of eslicarbazepine acetate in a mouse model of KCNQ2-related self-limited epilepsy.
Topics: Animals; Anticonvulsants; Dibenzazepines; Epilepsy; Epilepsy, Temporal Lobe; KCNQ2 Potassium Channel; Mice; Seizures | 2022 |
Eslicarbazepine acetate for the treatment of status epilepticus.
Topics: Aged; Anticonvulsants; Dibenzazepines; Epilepsy; Humans; Hyponatremia; Middle Aged; Status Epilepticus; Treatment Outcome | 2023 |
Potential efficacy and safety of eslicarbazepine acetate oral loading in patients with epilepsy.
Topics: Adult; Anticonvulsants; Dibenzazepines; Epilepsy; Humans; Seizures; Treatment Outcome | 2023 |
A Prospective Longitudinal Study of the Effects of Eslicarbazepine Acetate Treatment on Bone Density and Metabolism in Patients with Focal-Onset Epilepsy.
Topics: Adult; Anticonvulsants; Bone Density; Bone Diseases, Metabolic; Dibenzazepines; Epilepsies, Partial; Epilepsy; Female; Humans; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2023 |
Eslicarbazepine acetate in post-stroke epilepsy: Clinical practice evidence from Euro-Esli.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Dibenzazepines; Epilepsy; Female; Humans; Male; Middle Aged; Seizures; Stroke; Treatment Outcome; Young Adult | 2020 |
Distinct effects on cAMP signaling of carbamazepine and its structural derivatives do not correlate with their clinical efficacy in epilepsy.
Topics: Adenylyl Cyclases; Anticonvulsants; Calcium Signaling; Carbamazepine; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Dibenzazepines; Epilepsy; HEK293 Cells; Humans; Oxcarbazepine; Seizures; Signal Transduction; Treatment Outcome | 2020 |
Eslicarbazepine acetate response in intellectual disability population versus general population.
Topics: Adult; Anticonvulsants; Dibenzazepines; Epilepsy; Female; Humans; Intellectual Disability; Male; Middle Aged; Prevalence; Retrospective Studies; Seizures | 2021 |
[Alzemon: a prospective follow-up study of eslicarbazepine acetate monotherapy in patients with newly diagnosed epilepsy].
Topics: Adult; Aged; Anticonvulsants; Dibenzazepines; Epilepsy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies | 2021 |
Psychiatric side effects and antiepileptic drugs: Observations from prospective audits.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Dibenzazepines; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Female; Fructose; Humans; Lacosamide; Levetiracetam; Male; Medical Audit; Mental Disorders; Middle Aged; Nitriles; Piracetam; Pregabalin; Prospective Studies; Pyridones; Retrospective Studies; Seizures; Sodium Channel Blockers; Topiramate; Young Adult | 2017 |
Effects of eslicarbazepine acetate on lipid profile and sodium levels in patients with epilepsy.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Dibenzazepines; Epilepsy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Retrospective Studies; Sodium; Triglycerides; Voltage-Gated Sodium Channel Blockers | 2017 |
Eslicarbazepine acetate as a replacement for levetiracetam in people with epilepsy developing behavioral adverse events.
Topics: Adult; Anticonvulsants; Dibenzazepines; Drug Substitution; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Female; Humans; Levetiracetam; Male; Mental Disorders; Middle Aged; Psychiatric Status Rating Scales; Retrospective Studies; Seizures; Substance Withdrawal Syndrome; Treatment Outcome; Voltage-Gated Sodium Channel Blockers | 2018 |
Response: Comparing the dosages of lacosamide, eslicarbazepine acetate, and controlled-release carbamazepine in noninferiority epilepsy monotherapy trials: How much "fair" is "fair".
Topics: Acetamides; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dibenzazepines; Epilepsy; Humans; Lacosamide | 2018 |
Comparing the dosages of lacosamide, eslicarbazepine acetate, and controlled-release carbamazepine in noninferiority epilepsy monotherapy trials: How much "fair" is "fair"?
Topics: Acetamides; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dibenzazepines; Epilepsy; Humans; Lacosamide | 2018 |
Antiepileptic drugs-induced hyponatremia: Review and analysis of 560 hospitalized patients.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Dibenzazepines; Epilepsy; Female; Hospitalization; Humans; Hyponatremia; Incidence; Male; Oxcarbazepine; Young Adult | 2018 |
Chronic hyponatremia - Why care? A case report.
Topics: Anticonvulsants; Chronic Disease; Dibenzazepines; Epilepsy; Humans; Hyponatremia; Male; Middle Aged; Sodium | 2018 |
[Antiepileptic drugs].
Topics: Anticonvulsants; Dibenzazepines; Epilepsy; Humans; Nitriles; Pyridones; Pyrrolidinones | 2018 |
Levels of anger in epilepsy patients treated with eslicarbazepine acetate.
Topics: Adult; Anger; Anticonvulsants; Dibenzazepines; Epilepsy; Female; Humans; Male; Middle Aged; Quality of Life; Sodium Channel Blockers | 2019 |
Eslicarbazepine acetate in epilepsy patients with psychiatric comorbidities and intellectual disability: Clinical practice findings from the Euro-Esli study.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Dibenzazepines; Epilepsy; Female; Humans; Intellectual Disability; Male; Mental Disorders; Middle Aged; Treatment Outcome; Young Adult | 2019 |
MONOZEB: Long-term observational study of eslicarbazepine acetate monotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Dibenzazepines; Dizziness; Epilepsy; Female; Humans; Hyponatremia; Longitudinal Studies; Male; Middle Aged; Retrospective Studies; Seizures; Sleepiness; Young Adult | 2019 |
Aptiom (eslicarbazepine acetate) as a dual inhibitor of β-secretase and voltage-gated sodium channel: advancement in Alzheimer's disease-epilepsy linkage via an enzoinformatics study.
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Dibenzazepines; Epilepsy; Hydrophobic and Hydrophilic Interactions; Molecular Docking Simulation; Molecular Structure; Protease Inhibitors; Voltage-Gated Sodium Channel Blockers; Voltage-Gated Sodium Channels | 2014 |
Targeting pharmacoresistant epilepsy and epileptogenesis with a dual-purpose antiepileptic drug.
Topics: Adolescent; Adult; Animals; Anticonvulsants; Child; Child, Preschool; CHO Cells; Convulsants; Cricetulus; Dibenzazepines; Epilepsy; Hippocampus; Humans; In Vitro Techniques; Male; Mice; Middle Aged; Pilocarpine; Postural Balance; Rats; Rats, Wistar; Scopolamine; Young Adult | 2015 |
New hope for the treatment of epilepsy.
Topics: Animals; Anticonvulsants; Dibenzazepines; Epilepsy; Humans; Male | 2015 |
Practical guidance and considerations for transitioning patients from oxcarbazepine or carbamazepine to eslicarbazepine acetate--Expert opinion.
Topics: Anticonvulsants; Attitude of Health Personnel; Carbamazepine; Dibenzazepines; Drug Substitution; Drug Therapy, Combination; Epilepsy; Humans; Oxcarbazepine; Voltage-Gated Sodium Channel Blockers | 2015 |
Assessing long-term effects of eslicarbazepine acetate on lipid metabolism profile, sodium values and liver function tests.
Topics: Adult; Anticonvulsants; Carbamazepine; Cholesterol; Dibenzazepines; Dyslipidemias; Epilepsy; Female; Humans; Liver Function Tests; Male; Outpatients; Oxcarbazepine; Retrospective Studies; Sodium; Time Factors; Triglycerides | 2015 |
EPICON consensus: recommendations for proper management of switching to eslicarbazepine acetate in epilepsy.
Topics: Anticonvulsants; Carbamazepine; Consensus; Delphi Technique; Dibenzazepines; Drug Substitution; Epilepsy; Guidelines as Topic; Humans; Neurologists; Oxcarbazepine; Surveys and Questionnaires; Voltage-Gated Sodium Channel Blockers | 2018 |
Transition from oxcarbazepine to eslicarbazepine acetate: A single center study.
Topics: Adult; Aged; Carbamazepine; Dibenzazepines; Drug Substitution; Epilepsy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Oxcarbazepine; Registries; Voltage-Gated Sodium Channel Blockers; Young Adult | 2017 |
Pharmacokinetics, efficacy, and tolerability of eslicarbazepine acetate in children and adolescents with epilepsy.
Topics: Adolescent; Anticonvulsants; Area Under Curve; Child; Child, Preschool; Dibenzazepines; Drug Resistance; Epilepsy; Female; Half-Life; Humans; Male; Seizures | 2008 |
[Abrupt switch from extended-release oxcarbazepine to eslicarbazepine acetate].
Topics: Adult; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dibenzazepines; Drug Therapy, Combination; Epilepsy; Female; Humans; Male; Middle Aged; Oxcarbazepine; Treatment Outcome; Young Adult | 2011 |
A chiral HPLC-UV method for the quantification of dibenz[b,f]azepine-5-carboxamide derivatives in mouse plasma and brain tissue: eslicarbazepine acetate, carbamazepine and main metabolites.
Topics: Animals; Anticonvulsants; Brain; Brain Chemistry; Carbamazepine; Chromatography, High Pressure Liquid; Dibenzazepines; Epilepsy; Humans; Male; Mice; Models, Animal | 2011 |
Neurotoxicity induced by antiepileptic drugs in cultured hippocampal neurons: a comparative study between carbamazepine, oxcarbazepine, and two new putative antiepileptic drugs, BIA 2-024 and BIA 2-093.
Topics: Animals; Anticonvulsants; Carbamazepine; Cell Survival; Cells, Cultured; Dibenzazepines; Epilepsy; Hippocampus; Immunohistochemistry; Neurons; Neurotoxicity Syndromes; Rats; Rats, Wistar; Reactive Oxygen Species; Toxicity Tests | 2004 |